ELTP · Elite Pharmaceuticals Inc /Nv/ · Analyst Estimates
$0.22
0.00 (-2.01%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$242.36M
Shares
1.08B
Volume · Oct 5
1.66M
Avg daily vol (3M)
765.21K
Analyst Estimates
Compare analyst forecasts for Elite Pharmaceuticals Inc /Nv/ across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
Source collection is delayed; the retained verified snapshot may not include newer publications.
Consensus not yet available
Source collection is delayed; the retained verified snapshot may not include newer publications.